Brought to you by 
ICIG acquires Genzyme Pharmaceuticals
03 Feb 2011
Executive Summary
Concurrent with finalizing the $265mm cash sale of its diagnostics division to Japanese pharmaco Sekisui Chemical Co. Ltd., Genzyme Corp. is now divesting its Genzyme Pharmaceuticals division to International Chemical Investors Group (ICIG).
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ICIG acquires Genzyme Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice